A new study led by researchers at Mass General Brigham suggests a nasal spray developed to target neuroinflammation could one ...

Can’t breathe without your nasal spray? You’re not alone. But here’s why that quick fix can cause long-term harm.

The Pharmaceutical Benefits Scheme (PBS) has introduced a groundbreaking treatment for Australians suffering from treatment-resistant depression. Starting May 1, Spravato, a ketamine-based nasal spray ...

ARS Pharmaceuticals has a recently launched needle-free epinephrine product for allergic reactions, neffy. See why I rate ...

Unlike older medications that target serotonin – a “feel-good” chemical in the brain – the ketamine-based nasal spray works ...

Winter: Most people find their allergies dormant during the winter months because most plants don't pollinate during winter.

A novel approach to treating depression derived from a popular club drug offers hope to tens of thousands of Australians ...

A controversial substance once tied to underground rave culture is now being hailed as a breakthrough for depression.

Total operating loss from continuing operations increased from $6.6 million in 2023 to $6.9 million in 2024. Research and ...

So, twins can be allergic to the same things, and it's more likely that they will be, based on their shared genetics and ...

Quadrivalent and high-dose vaccines offer diverse demographic needs, while digital platforms aid vaccine monitoring and distribution. A robust government backing, ongoing research and development, and ...

About Evoke Pharma, Inc. Evoke is a specialty pharmaceutical company focused primarily on the development of drugs to treat ...